Monk's moments: A rose by any other name ...
The 1950s were a golden age in medicine. The antibiotic era had seen the arrival of penicillin, erythromycin, streptomycin and isoniazid, all in the space of little over a decade, and with them the virtual eradication of many deadly infections. Viral disease appeared to be the last barrier, yet research into antiviral agents was unrewarding. Then in 1957, a young scientist, Dr Alick Isaacs, made the observation that certain cells, when infected with a virus, produce an agent that inhibits further viral infection. Could this perhaps be the long-sought ‘magic bullet’ against viral infections? But first, Isaacs pondered, what should the new material be called?
Dermatology in practice 2001; 9(6): 31–31
To continue reading this article, please sign in or register.